ePneumonia: Development of an Electronic Clinical Decision Support System for Community-Onset Pneumonia
NCT ID: NCT03358342
Last Updated: 2020-10-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
10000 participants
OBSERVATIONAL
2017-11-22
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Adaptation and Pilot Implementation of ePNa Clinical Decision Support for Utah Urgent Care Clinics
NCT04606849
Using Probability of Community-Acquired Pneumonia to Tailor Antimicrobials Among Inpatients
NCT05976581
Performance of New Diagnostic Methods in Older Adults With Pneumonia
NCT06092008
Definition of Sub-phenotypes of Pneumonia Based on the Respiratory Microbiome Composition to Predict Microbial and Clinical Treatment Failures
NCT06916481
Biomarker Guided Antibiotic Treatment in Community-Acquired Pneumonia
NCT03146182
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators have entered a robust phase of additional development and adaptation of ePneumonia into the Cerner Electronic Health Record (EHR) system. The objective of this study is to advance development of an evidence-based, electronic CDSS for pneumonia care with interoperability across EHRs in order to improve clinical outcomes and reduce healthcare resource utilization. The specific aim of this study is to evaluate the usability of ePneumonia and its associated impact on clinical, patient-centered and healthcare resource utilization outcomes in a stepped-wedge implementation study in 16 hospital EDs in the Intermountain Healthcare integrated health system.
* Hypothesis #1: Healthcare providers will affirm ePneumonia usability, lack of interference with clinical workflow and only minor unintended consequences of use.
* Hypothesis #2: In patients with community-onset pneumonia, ePneumonia use will improve clinical and patient-centered outcomes and decrease healthcare resource utilization.
One year of baseline clinical outcome data will be gathered for all 16 emergency departments. The first of 6 clusters of ED's will begin prospective data collection in January 2018, with the remaining coming on at 2 month intervals until ePneumonia has been deployed at all sites. An additional 1 year of data collection will be continued through 2019.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ED Patients treated using ePneumonia CDS
ED patients with community-acquired pneumonia treated in ED's after roll out of ePneumonia
ePneumonia CDS
ePneumonia clinical decision support system for community-onset pneumonia
Usual care
ED patients with pneumonia receiving usual care without electronic CDS
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ePneumonia CDS
ePneumonia clinical decision support system for community-onset pneumonia
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Intermountain Healthcare physicians working in the 16 ED's
Exclusion Criteria
* subsequent episodes of pneumonia within the study period, so as not to over-represent patients with recurrent pneumonia caused by recurrent aspiration or structural lung disease, and
* immunosuppressed patients, such as those with AIDS.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Intermountain Health Care, Inc.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nathan Dean
Section Chief of Pulmonary and Critical Care Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nathan Dean, MD
Role: PRINCIPAL_INVESTIGATOR
Intermountain Health Care, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cassia Regional Hospital
Burley, Idaho, United States
American Fork Hospital
American Fork, Utah, United States
Cedar City Hospital
Cedar City, Utah, United States
Delta Community Hospital
Delta, Utah, United States
Fillmore Hospital
Fillmore, Utah, United States
Heber Valley Hospital
Heber City, Utah, United States
Logan Regional Hospital
Logan, Utah, United States
Sanpete Valley Hospital
Mount Pleasant, Utah, United States
Intermountain Medical Center
Murray, Utah, United States
McKay-Dee Hospital
Ogden, Utah, United States
Orem Community Hospital
Orem, Utah, United States
Garfield Memorial Hospital
Panguitch, Utah, United States
Park City Medical Center
Park City, Utah, United States
Utah Valley Hospital
Provo, Utah, United States
Sevier Valley Hospital
Richfield, Utah, United States
Dixie Regional Medical Center
St. George, Utah, United States
Bear River Hospital
Tremonton, Utah, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Dean NC, Vines CG, Carr JR, Rubin JG, Webb BJ, Jacobs JR, Butler AM, Lee J, Jephson AR, Jenson N, Walker M, Brown SM, Irvin JA, Lungren MP, Allen TL. A Pragmatic, Stepped-Wedge, Cluster-controlled Clinical Trial of Real-Time Pneumonia Clinical Decision Support. Am J Respir Crit Care Med. 2022 Jun 1;205(11):1330-1336. doi: 10.1164/rccm.202109-2092OC.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ePneumonia - CDS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.